MRKR
Price
$1.46
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
16.58M
RCKT
Price
$2.52
Change
-$0.07 (-2.70%)
Updated
Jun 27 closing price
Capitalization
270.96M
43 days until earnings call
Interact to see
Advertisement

MRKR vs RCKT

Header iconMRKR vs RCKT Comparison
Open Charts MRKR vs RCKTBanner chart's image
Marker Therapeutics
Price$1.46
Change-$0.00 (-0.00%)
Volume$69.45K
Capitalization16.58M
Rocket Pharmaceuticals
Price$2.52
Change-$0.07 (-2.70%)
Volume$6.04M
Capitalization270.96M
MRKR vs RCKT Comparison Chart in %
Loading...
MRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRKR vs. RCKT commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRKR is a Hold and RCKT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (MRKR: $1.46 vs. RCKT: $2.52)
Brand notoriety: MRKR and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRKR: 56% vs. RCKT: 111%
Market capitalization -- MRKR: $16.58M vs. RCKT: $270.96M
MRKR [@Biotechnology] is valued at $16.58M. RCKT’s [@Biotechnology] market capitalization is $270.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRKR’s FA Score shows that 1 FA rating(s) are green whileRCKT’s FA Score has 1 green FA rating(s).

  • MRKR’s FA Score: 1 green, 4 red.
  • RCKT’s FA Score: 1 green, 4 red.
According to our system of comparison, both MRKR and RCKT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRKR’s TA Score shows that 4 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • MRKR’s TA Score: 4 bullish, 5 bearish.
  • RCKT’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RCKT is a better buy in the short-term than MRKR.

Price Growth

MRKR (@Biotechnology) experienced а +0.69% price change this week, while RCKT (@Biotechnology) price change was -6.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

RCKT is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($271M) has a higher market cap than MRKR($16.6M). MRKR YTD gains are higher at: -53.055 vs. RCKT (-79.992). MRKR has higher annual earnings (EBITDA): -6.13M vs. RCKT (-246.03M). RCKT has more cash in the bank: 318M vs. MRKR (13.7M). MRKR has less debt than RCKT: MRKR (0) vs RCKT (25.4M). MRKR has higher revenues than RCKT: MRKR (6.59M) vs RCKT (0).
MRKRRCKTMRKR / RCKT
Capitalization16.6M271M6%
EBITDA-6.13M-246.03M2%
Gain YTD-53.055-79.99266%
P/E RatioN/AN/A-
Revenue6.59M0-
Total Cash13.7M318M4%
Total Debt025.4M-
FUNDAMENTALS RATINGS
MRKR vs RCKT: Fundamental Ratings
MRKR
RCKT
OUTLOOK RATING
1..100
8770
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
14
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
5866
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (14) in the Biotechnology industry is in the same range as MRKR (21) in the Other Consumer Services industry. This means that RCKT’s stock grew similarly to MRKR’s over the last 12 months.

RCKT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MRKR (100) in the Other Consumer Services industry. This means that RCKT’s stock grew similarly to MRKR’s over the last 12 months.

RCKT's SMR Rating (97) in the Biotechnology industry is in the same range as MRKR (98) in the Other Consumer Services industry. This means that RCKT’s stock grew similarly to MRKR’s over the last 12 months.

MRKR's Price Growth Rating (58) in the Other Consumer Services industry is in the same range as RCKT (66) in the Biotechnology industry. This means that MRKR’s stock grew similarly to RCKT’s over the last 12 months.

MRKR's P/E Growth Rating (100) in the Other Consumer Services industry is in the same range as RCKT (100) in the Biotechnology industry. This means that MRKR’s stock grew similarly to RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MRKRRCKT
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
70%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DTNOF1.26N/A
N/A
DNO ASA
RROTF2.35N/A
N/A
Roots Corporation
NPTVF21.76N/A
N/A
Nippon Television Network Corporation
AMADF80.90-0.70
-0.86%
Amadeus IT Group SA
VCUFF0.07N/A
-5.36%
Vizsla Copper Corp.

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with SVRA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
-2.90%
SVRA - RCKT
61%
Loosely correlated
N/A
PRTA - RCKT
53%
Loosely correlated
-1.62%
INZY - RCKT
44%
Loosely correlated
-0.25%
ERAS - RCKT
43%
Loosely correlated
N/A
LENZ - RCKT
43%
Loosely correlated
+0.23%
More